Ledger.Open graph →
SEC Form D · filed July 24, 2023

CND Life Sciences, Inc

Offering
$1.5M
Sold
$1.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SCOTTSDALE, AZ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Enrique J. Carrazana · Coral Gables, FLDirectorPeter J. Harris · Brookline, MAExec · DirectorRichard J. Morello · Atlanta, GAExec · DirectorTodd J. Levine · Paradise Valley, AZDirectorRobert Hartog · Denver, CODirectorHaakon Overli · London, United KingdomExec · DirectorAlex Appleton · London, United KingdomExec · DirectorMatthew Shaw · London, United KingdomDirectorTodd Sachse · Detroit, MIExec · DirectorMerredith Treaster · San Francisco, CAExec · DirectorCheryl R. Zabala · New York, NYDirectorAlexander M. Liang, M.D · Dallas, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗